环磷酰胺增强人体免疫反应。 - Suppr

Suppr

超能文献

Augmentation of the human immune response by cyclophosphamide.

作者信息

Berd D, Mastrangelo M J, Engstrom P F, Paul A, Maguire H

出版信息

Cancer Res. 1982 Nov;42(11):4862-6.

PMID:7127320

Abstract

摘要

相似文献

Augmentation of the human immune response by cyclophosphamide.环磷酰胺增强人体免疫反应。

Cancer Res. 1982 Nov;42(11):4862-6.

Potentiation of human cell-mediated and humoral immunity by low-dose cyclophosphamide.低剂量环磷酰胺增强人体细胞介导免疫和体液免疫

Cancer Res. 1984 Nov;44(11):5439-43.

A phase 2 study of intermittent high-dose cyclophosphamide therapy of advanced gastrointestinal cancer.

Cancer Res. 1973 Oct;33(10):2218-20.

Phase II study of cyclophosphamide and cytarabine in the treatment of metastatic adenocarcinoma of the colon and rectum.

Cancer Treat Rep. 1981 Jan-Feb;65(1-2):163-4.

Effect of 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea adjuvant therapy on the immune response of patients with malignant melanoma.

Cancer Res. 1979 Nov;39(11):4472-6.

Low dosage methotrexate (NSC-740) and cyclophosphamide (NSC 26271) for solid tumors.

Cancer Chemother Rep. 1970 Feb;54(1):41-6.

Immunotherapy of human solid tumors with Bacillus Calmette-Guérin: prolongation of disease-free interval and survival in malignant melanoma, breast, and colorectal cancer.用卡介苗对人类实体瘤进行免疫治疗：延长恶性黑色素瘤、乳腺癌和结直肠癌的无病间期及生存期。

Ann N Y Acad Sci. 1976;277(00):135-59. doi: 10.1111/j.1749-6632.1976.tb41695.x.

Tumor spread and reactivity to DNCB: (2, 4 Dinitro-1 chlorobenzene) skin test.

Int Surg. 1972 Aug;57(8):617-9.

Phase II trial of bisantrene in advanced colorectal carcinoma.比生群用于晚期结直肠癌的II期试验。

Cancer Treat Rep. 1983 Mar;67(3):307-8.

Phase II trial: mitomycin c and methotrexate combination therapy for advanced colorectal carcinoma.

Cancer Treat Rep. 1981 May-Jun;65(5-6):535.

引用本文的文献

Portrait of an autologous cancer vaccine: Then and now.自体肿瘤疫苗的描绘：过去与现在。

Hum Vaccin Immunother. 2023 Dec 31;19(1):2172925. doi: 10.1080/21645515.2023.2172925. Epub 2023 Feb 8.

The immune modifying effects of chemotherapy and advances in chemo-immunotherapy.化疗的免疫调节作用及化疗免疫治疗的进展。

Pharmacol Ther. 2022 Aug;236:108111. doi: 10.1016/j.pharmthera.2022.108111. Epub 2022 Jan 10.

Cyclophosphamide inhibits the progression of Meniere's disease by reducing the generation of circulating immune complex.环磷酰胺通过减少循环免疫复合物的产生来抑制梅尼埃病的进展。

Exp Ther Med. 2021 Oct;22(4):1177. doi: 10.3892/etm.2021.10611. Epub 2021 Aug 13.

IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers.用于头颈癌患者免疫治疗的IRX-2天然细胞因子生物制剂。

Onco Targets Ther. 2018 Jun 28;11:3731-3746. doi: 10.2147/OTT.S165411. eCollection 2018.

Active idiotypic vaccination versus control immunotherapy for follicular lymphoma.滤泡性淋巴瘤的主动独特型疫苗接种与对照免疫疗法

J Clin Oncol. 2014 Jun 10;32(17):1797-803. doi: 10.1200/JCO.2012.43.9273. Epub 2014 May 5.

Immunologic consequences of chemotherapy for ovarian cancer: impaired responses to the influenza vaccine.化疗对卵巢癌的免疫后果：对流感疫苗的反应受损。

Vaccine. 2013 Nov 4;31(46):5435-42. doi: 10.1016/j.vaccine.2013.09.001. Epub 2013 Sep 13.

Increased lymphocyte infiltration in patients with head and neck cancer treated with the IRX-2 immunotherapy regimen.在接受 IRX-2 免疫治疗方案治疗的头颈部癌症患者中，淋巴细胞浸润增加。

Cancer Immunol Immunother. 2012 Jun;61(6):771-82. doi: 10.1007/s00262-011-1134-z. Epub 2011 Nov 6.

Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission.I 期/II 期随机试验，比较树突状细胞疫苗联合或不联合环磷酰胺用于巩固治疗初次或二次缓解的晚期卵巢癌。

Cancer Immunol Immunother. 2012 May;61(5):629-41. doi: 10.1007/s00262-011-1081-8. Epub 2011 Oct 22.

Immunomodulatory effects of cyclophosphamide and implementations for vaccine design.环磷酰胺的免疫调节作用及其在疫苗设计中的应用。

Semin Immunopathol. 2011 Jul;33(4):369-83. doi: 10.1007/s00281-011-0245-0. Epub 2011 May 25.

Phase III multicenter clinical trial of the sialyl-TN (STn)-keyhole limpet hemocyanin (KLH) vaccine for metastatic breast cancer.STn-钥孔戚血蓝蛋白（KLH）疫苗治疗转移性乳腺癌的 III 期多中心临床试验。

Oncologist. 2011;16(8):1092-100. doi: 10.1634/theoncologist.2010-0307. Epub 2011 May 14.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验